UpHealth ( (UPHL) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
UpHealth, Inc. has filed a Form 12b-25, notifying investors of a delayed Form 10-Q (Quarter Report) for the quarter ended March 31, 2026. The company is based in Palo Alto, California, and the late filing extends an already long list of missing quarterly and yearly reports.
Management says the delay stems from the time and effort needed to compile, distribute and review all information required in the Form 10-Q (Quarter Report). They argue that filing on time would impose undue hardship and expense, without citing any specific audit issues or external disruptions.
UpHealth has not committed to a precise new filing date for this Form 10-Q (Quarter Report). The company also acknowledges that multiple prior Forms 10-Q (Quarter Report) and two Forms 10-K (Yearly Report) for 2024 and 2025 are still outstanding, underscoring a prolonged reporting backlog.
The company states it does not expect a significant change in results of operations compared with the same quarter of the prior year. No preliminary financial figures are provided, and any future statements about results should be treated as forward-looking and subject to revision once the delayed Form 10-Q (Quarter Report) is filed.
UpHealth indicates it is working to complete its disclosure obligations and clear its accumulation of late SEC reports. The notification is signed by Acting Chief Executive Officer Jay W. Jennings on May 15, 2026, signaling executive-level responsibility for resolving the company’s reporting delays.
Spark’s Take on UPHL Stock
According to Spark, TipRanks’ AI Analyst, UPHL is a Neutral.
UpHealth’s overall score reflects significant risks related to its financial performance, including profitability and liquidity challenges. While revenue growth is encouraging, the lack of technical analysis data and poor valuation metrics are concerning. The absence of clear earnings call guidance adds uncertainty to the company’s outlook.
To see Spark’s full report on UPHL stock, click here.
More about UpHealth
Technical Sentiment Signal: Sell
Current Market Cap: $1,893
Learn more about UPHL stock on TipRanks’ Stock Analysis page.